RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer

FEBS Letters

Volumn 585, Issue 15, 2011, Pages 2537-2544

  Flavin, Padraic ^a   Redmond, Aisling ^a   McBryan, Jean ^a   Cocchiglia, Sinead ^a   Tibbitts, Paul ^a   Fahy Browne, Patrick ^a   Kay, Elaine ^a   Treumann, Achim ^a   Perrem, Kilian ^a   McIlroy, Marie ^a   Hill, Arnold D K ^a   Young, Leonie S ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

c Myc; Colon cancer; hTERT; RuvBl2

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATASE; PROTEIN RUVB12; REGULATOR PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER PATIENT; CELL NUCLEUS; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHADENOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

CARRIER PROTEINS; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEOMICS; PROTO-ONCOGENE PROTEIN C-ETS-2; TELOMERASE; TRANSCRIPTION, GENETIC;

EID: 79960907716     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.07.005     Document Type: Article

References (50)

1. Blasco, M.A. (2007) Telomere length, stem cells and aging. Nat. Chem. Biol. 3, 640-649.
2. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
3. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
4. Shay, J.W. and Wright, W.E. (1989) Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res. 184, 109-118. (Pubitemid 19233392)
5. Cohen, S.B., Graham, M.E., Lovrecz, G.O., Bache, N., Robinson, P.J. and Reddel, R.R. (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315, 1850-1853. (Pubitemid 46580145)
6. Fu, D. and Collins, K. (2007) Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol. Cell 28, 773-785. (Pubitemid 350217053)
7. Smogorzewska, A. and de Lange, T. (2004) Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208. (Pubitemid 39050367)
8. Atkinson, S.P., Hoare, S.F., Glasspool, R.M. and Keith, W.N. (2005) Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 65, 7585-7590. (Pubitemid 41297229)
9. Wang, S., Yuan, Y., Liao, L., Kuang, S.Q., Tien, J.C., O'Malley, B.W. and Xu, J. (2009) Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc. Natl. Acad. Sci. USA 106, 151-156.
10. Zinn, R.L., Pruitt, K., Eguchi, S., Baylin, S.B. and Herman, J.G. (2007) HTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 67, 194-201. (Pubitemid 46142775)
11. Kanaya, T., Kyo, S., Hamada, K., Takakura, M., Kitagawa, Y., Harada, H. and Inoue, M. (2000) Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin. Cancer Res. 6, 1239-1247. (Pubitemid 30226203)
12. Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D. and Rotter, V. (2004) P53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem. 279, 50976-50985. (Pubitemid 40017838)
13. Xiong, J., Fan, S., Meng, Q., Schramm, L., Wang, C., Bouzahza, B., Zhou, J., Zafonte, B., Goldberg, I.D., Haddad, B.R., Pestell, R.G. and Rosen, E.M. (2003) BRCA1 inhibition of telomerase activity in cultured cells. Mol. Cell Biol. 23, 8668-8690. (Pubitemid 37433370)
14. Xu, D., Wang, Q., Gruber, A., Bjorkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K.G. and Pisa, P. (2000) Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 19, 5123-5133.
15. Zhou, C. and Liu, J. (2003) Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells. Biochem. Biophys. Res. Commun. 303, 130-136. (Pubitemid 36338217)
16. Deng, W.G., Jayachandran, G., Wu, G., Xu, K., Roth, J.A. and Ji, L. (2007) Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. J. Biol. Chem. 282, 26460-26470. (Pubitemid 47443763)
17. Greenberg, R.A., O'Hagan, R.C., Deng, H., Xiao, Q., Hann, S.R., Adams, R.R., Lichtsteiner, S., Chin, L., Morin, G.B. and DePinho, R.A. (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226. (Pubitemid 29085995)
18. Kang, X., Chen, W., Kim, R.H., Kang, M.K. and Park, N.H. (2009) Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells. Oncogene 28, 565-574.
19. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H. and Inoue, M. (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28, 669-677. (Pubitemid 30068249)
20. Maida, Y., Kyo, S., Kanaya, T., Wang, Z., Yatabe, N., Tanaka, M., Nakamura, M., Ohmichi, M., Gotoh, N., Murakami, S. and Inoue, M. (2002) Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21, 4071-4079. (Pubitemid 34712874)
21. Wu, K.J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J. and Dalla-Favera, R. (1999) Direct activation of TERT transcription by c-MYC. Nat. Genet. 21, 220-224. (Pubitemid 29070372)
22. Xu, D., Dwyer, J., Li, H., Duan, W. and Liu, J.P. (2008) Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J. Biol. Chem. 283, 23567-23580.
23. Bazarov, A.V., Hines, W.C., Mukhopadhyay, R., Beliveau, A., Melodyev, S., Zaslavsky, Y. and Yaswen, P. (2009) Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes. Cell Cycle 8, 3373-3378.
24. Lebel, R., McDuff, F.O., Lavigne, P. and Grandbois, M. (2007) Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter. Biochemistry 46, 10279-10286. (Pubitemid 350067621)
25. Galang, C.K., Garcia-Ramirez, J., Solski, P.A., Westwick, J.K., Der, C.J., Neznanov, N.N., Oshima, R.G. and Hauser, C.A. (1996) Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem. 271, 7992-7998. (Pubitemid 26108618)
26. Myers, E., Hill, A.D., Kelly, G., McDermott, E.W., O'Higgins, N.J., Buggy, Y. and Young, L.S. (2005) Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin. Cancer Res. 11, 2111-2122. (Pubitemid 40490167)
27. Foulds, C.E., Nelson, M.L., Blaszczak, A.G. and Graves, B.J. (2004) Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol. Cell Biol. 24, 10954-10964. (Pubitemid 39603149)
28. Seth, A. and Watson, D.K. (2005) ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer 41, 2462-2478. (Pubitemid 41540623)
29. Ito, Y., Takeda, T., Okada, M. and Matsuura, N. (2002) Expression of ets-1 and ets-2 in colonic neoplasms. Anticancer Res. 22, 1581-1584. (Pubitemid 34839167)
30. Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B., Steen, H., Pandey, A. and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1, 376-386.
31. Venteicher, A.S., Meng, Z., Mason, P.J., Veenstra, T.D. and Artandi, S.E. (2008) Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 132, 945-957. (Pubitemid 351381739)
32. Li, W., Zeng, J., Li, Q., Zhao, L., Liu, T., Bjorkholm, M., Jia, J. and Xu, D. (2010) Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Mol. Cancer 9, 132.
33. Al-azawi, D., Ilroy, M.M., Kelly, G., Redmond, A.M., Bane, F.T., Cocchiglia, S., Hill, A.D. and Young, L.S. (2008) Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer. Oncogene 27, 3021-3031. (Pubitemid 351668011)
34. Yang, B.S., Hauser, C.A., Henkel, G., Colman, M.S., Van Beveren, C., Stacey, K.J., Hume, D.A., Maki, R.A. and Ostrowski, M.C. (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell Biol. 16, 538-547. (Pubitemid 26029092)
35. McIlroy, M., McCartan, D., Early, S., Pennington, S., Hill, A.D. and Young, L.S. (2010) Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected]. Cancer Res. 70, 1585-1594.
36. Cong, Y.S., Wen, J. and Bacchetti, S. (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8, 137-142. (Pubitemid 29039059)
37. Harvey, J.M., Clark, G.M., Osborne, C.K. and Allred, D.C. (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J. Clin. Oncol. 17, 1474-1481. (Pubitemid 29220854)
38. Yuan, J., Yang, B.M., Zhong, Z.H., Shats, I., Milyavsky, M., Rotter, V., Lock, R.B., Reddel, R.R. and MacKenzie, K.L. (2009) Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene 28, 2678-2689.
39. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248.
40. Cesare, A.J. and Reddel, R.R. (2008) Telomere uncapping and alternative lengthening of telomeres. Mech. Ageing Dev. 129, 99-108.
41. Jha, S. and Dutta, A. (2009) RVB1/RVB2: running rings around molecular biology. Mol. Cell 34, 521-533.
42. Goueli, B.S. and Janknecht, R. (2003) Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22, 8042-8047. (Pubitemid 37175868)
43. Wood, M.A., McMahon, S.B. and Cole, M.D. (2000) An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol. Cell 5, 321-330. (Pubitemid 30628090)
44. Rousseau, B., Menard, L., Haurie, V., Taras, D., Blanc, J.F., Moreau-Gaudry, F., Metzler, P., Hugues, M., Boyault, S., Lemiere, S., Canron, X., Costet, P., Cole, M., Balabaud, C., Bioulac-Sage, P., Zucman-Rossi, J. and Rosenbaum, J. (2007) Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 46, 1108-1118. (Pubitemid 350144775)
45. Talantov, D., Mazumder, A., Yu, J.X., Briggs, T., Jiang, Y., Backus, J., Atkins, D. and Wang, Y. (2005) Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11, 7234-7242. (Pubitemid 41507680)
46. Sanchez-Carbayo, M., Socci, N.D., Lozano, J., Saint, F. and Cordon-Cardo, C. (2006) Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24, 778-789. (Pubitemid 46622045)
47. Terrin, L., Rampazzo, E., Pucciarelli, S., Agostini, M., Bertorelle, R., Esposito, G., DelBianco, P., Nitti, D. and De Rossi, A. (2008) Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin. Cancer Res. 14, 7444-7451.
48. Gertler, R., Rosenberg, R., Stricker, D., Friederichs, J., Hoos, A., Werner, M., Ulm, K., Holzmann, B., Nekarda, H. and Siewert, J.R. (2004) Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J. Clin. Oncol. 22, 1807-1814. (Pubitemid 41095170)
49. Naito, Y., Takagi, T., Handa, O., Ishikawa, T., Matsumoto, N., Yoshida, N., Kato, H., Ando, T., Takemura, T., Itani, K., Hisatomi, H., Tsuchihashi, Y. and Yoshikawa, T. (2001) Telomerase activity and expression of telomerase RNA component and catalytic subunits in precancerous and cancerous colorectal lesions. Tumour Biol. 22, 374-382. (Pubitemid 34062949)
50. Lam, A.K., Ong, K. and Ho, Y.H. (2008) HTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features. Int. J. Colorectal Dis. 23, 587-594.